Authors:
de Jong, M
Breeman, WAP
Bernard, BF
Bakker, WH
Schaar, M
van Gameren, A
Bugaj, JE
Erion, J
Schmidt, M
Srinivasan, A
Krenning, EP
Citation: M. De Jong et al., [Lu-177-DOTA(0), Tyr(3)]octreotate for somatostatin receptor-targeted radionuclide therapy, INT J CANC, 92(5), 2001, pp. 628-633
Authors:
Bernard, BF
Krenning, E
Breeman, WAP
Visser, TJ
Bakker, WH
Srinivasan, A
De Jong, M
Citation: Bf. Bernard et al., Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy, NUCL MED C, 21(11), 2000, pp. 1079-1085
Authors:
de Jong, M
Breeman, WAP
Bernard, BF
van Gameren, A
de Bruin, E
Bakker, WH
van der Pluijm, ME
Visser, TJ
Macke, HR
Krenning, EP
Citation: M. De Jong et al., Tumour uptake of the radiolabelled somatostatin analogue [DOTA(0),TYR3]octreotide is dependent on the peptide amount, EUR J NUCL, 26(7), 1999, pp. 693-698
Authors:
de Jong, M
Bakker, WH
Bernard, BF
Valkema, R
Kwekkeboom, DJ
Reubi, JC
Srinivasan, A
Schmidt, M
Krenning, EP
Citation: M. De Jong et al., Preclinical and initial clinical evaluation of In-111-labeled nonsulfated CCK8 analog: A peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy, J NUCL MED, 40(12), 1999, pp. 2081-2087
Authors:
Breeman, WAP
De Jong, M
Bernard, BF
Kwekkeboom, DJ
Srinivasan, A
Van der Pluijm, ME
Hofland, LJ
Visser, TJ
Krenning, EP
Citation: Wap. Breeman et al., Pre-clinical evaluation of [In-111-DTPA-Pro(1), Tyr(4)] bombesin, a new radioligand for bombesin-receptor scintigraphy, INT J CANC, 83(5), 1999, pp. 657-663
Authors:
Breeman, WAP
Hofland, LJ
de Jong, M
Bernard, BF
Srinivasan, A
Kwekkeboom, DJ
Visser, TJ
Krenning, EP
Citation: Wap. Breeman et al., Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy, INT J CANC, 81(4), 1999, pp. 658-665